说明与适用边界
此页按所列地区、版本归档。标签内容可能更新，具体产品请核对原始来源；本站关联表示阅读线索，不表示药品与器械可兼容或可替换。
spl product data elements
Triple Antibiotic Bacitracin zinc, Neomycin sulfate , Polymyxin B sulfate. LIGHT MINERAL OIL WHITE PETROLATUM BACITRACIN ZINC BACITRACIN NEOMYCIN SULFATE NEOMYCIN POLYMYXIN B SULFATE POLYMYXIN B
活性成分 / Active ingredient
Active ingredients (each gram contains) Bacitracin zinc 400 units Neomycin sulfate 3.5 mg Polymyxin B sulfate 5,000 units
用途 / Purpose
Purpose First aid antibiotic
儿童安全 / Keep out of reach of children
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
适应证 / Indications and usage
Uses first aid to help prevent infection in minor:● cuts ● scrapes ● burns
警告 / Warnings
Warnings For external use only.
咨询医生 / Ask a doctor
Ask Doctor Before Use Ask Doctor before use if you have deep or puncture wounds, animal bites, or serious burns.
禁用事项 / Do not use
Do Not Use In the eyes Over large areas of the body If you are allergic to any of the ingredients
停用事项 / Stop use
Stop Use and ask a doctor Stop Use and ask a doctor if Condition persists or gets worse You need to use longer than 1 week A rash or other allergic reaction develops
用法用量原文 / Dosage and administration
Directions ● clean the affected area and dry thoroughly. ● apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily ● may be covered with a sterile bandage.
辅料 / Inactive ingredients
Inactive ingredient light Mineral Oil, White Petrolatum
spl unclassified section
Other information ● store at 20° to 25°C ( 68° to 77°F)
Manufactured For Manufactured for Urgent First Aid® 2603 Industry Street Oceanside, CA 92054 www.urgentfirstaid.com
questions
Questions? Call 1-760-642-2638
package label principal display panel
CDER URG600Triple antibiotic ointment 6939612505
来源、版本与许可
- 资料类型
- 美国药品标签原文
- 版本
- 2 / 20241220
- 获取时间
- 2026-10-08
- 许可
- openFDA public data; retain original label attribution. See 查看来源 and dataset source notices. Public access does not imply approval or unrestricted rights to every submitted label.